Fosun Pharma USA Inc. is a wholly owned subsidiary of Fosun Pharma with a focus on building a fully integrated innovative biopharmaceutical company focused on the US market. With the backing of one of the strongest Pharma players in China, Fosun Pharma USA is actively looking to partner with late development stage companies globally to build or support the US commercialization of product for unmet medical needs.
Innovative R&D is the core driver
for sustainable growth of Fosun Pharma USA Inc.
Fosun Pharma US Innovation Hub (FUSION BioVenture) is an incubation, innovation, and strategic investment platform of Fosun Pharma
A leading player in specialty generics and high barrier, complex and innovative 505b(2) products
Adhering to Independent Innovation, Efforts in Covid 19 pandemic control and beyond
We are now looking for late development stage (phase 2 and beyond) or commercial stage innovative products to in-license/partner or acquire for the USA market. While we can facilitate partnership with our parent company for the Chinese market, our clear focus is on US rights for innovative biopharmaceuticals.
104 Carnegie Center Drive, Suite 204
Princeton, NJ 08540
(609) 250-2802
info.usa@fosunpharma.com
Customer Service: (833) 291-9645
Adverse Event/ Quality Concern: (866) 611-376202
© 2022 Fosun Pharma USA Inc. All rights reserved.
